🇮🇳

Index Intelligence

· daily

BSE Auto Sector Regulatory Filings — May 09, 2026

The India BSE AUTO sector filings from May 9, 2026, reveal mixed momentum with Mahindra & Mahindra driving growth through 12.6% YoY total sales increase to 92,631 units, fueled by 101% YoY surge in electric Origin SUV sales (2,991 to 6,023 units) and 47.2% export growth to 5,007 units, though offset by diesel model declines like Thar (-5.4%) and Scorpio (-6.8%). TVS Motor shows proactive expansion via ESOP grants of 22,998 options (vesting exercisable within 4 years) and a positive launch of premium Ronin motorcycle variant in Sri Lanka, emphasizing international presence in 80 countries. Balkrishna Industries made Q4/FY26 earnings call recording available, signaling post-results transparency but no new metrics disclosed. Portfolio-level trends highlight EV and export acceleration amid diesel weakness and model discontinuations (e.g., XUV700 near zero), with neutral-to-mixed sentiment (1 positive, 1 mixed, 2 neutral). Implications point to sector pivot towards electrification and exports, creating alpha in outperformers like Mahindra EVs while flagging diesel exposure risks. No insider trading, capital allocation, or M&A noted; focus on operational metrics and product catalysts.

4 medium 4 total filings
· daily

BSE IT Technology Sector Regulatory Filings — May 09, 2026

In the India BSE IT stream for May 9, 2026, both filings exhibit neutral sentiment with low materiality (avg 2.5/10), highlighting investor engagement and potential institutional activity without directional financial trends. Hexaware Technologies announced participation in the DAM Capital IT Investor conference on May 13, 2026, featuring group and one-on-one meetings to boost visibility. Happiest Minds Technologies disclosed a Regulation 29(2) filing from SBI Mutual Fund, signaling possible substantial shareholding changes in the tech sector, though lacking specifics on volume or direction. No period-over-period comparisons (YoY/QoQ revenue, margins), insider trading, capital allocation, or forward-looking guidance were detailed in enriched data, limiting quantitative trends. Portfolio-level patterns show neutral stance across constituents, with opportunities in DII interest but risks from disclosure ambiguity. Overall implications point to time-sensitive monitoring of the investor event and MF updates for potential conviction signals in a steady IT sector.

2 medium 2 total filings
· daily

BSE Bankex Banking Sector Regulatory Filings — May 09, 2026

Across the three filings in the India BSE BANKEX stream, key themes include institutional investor activity from SBI Mutual Fund (SBI MF) signaling potential confidence in non-bank sectors like exports and technology, contrasted by a high-materiality fraud classification impacting Punjab National Bank (PNB) via a ₹201.51 Cr loan to Reliance Communications subsidiary. No explicit period-over-period financial trends (YoY/QoQ revenue, margins) are available in these disclosures, limiting quantitative growth insights, but ongoing CIRP protections since June 2019 for RCOM provide a stable insolvency backdrop amid fraud allegations involving ₹1,110.50 Cr fictitious debtors. SBI MF's dual Regulation 29(2) disclosures on Gokaldas Exports and Happiest Minds indicate substantial shareholding changes, potentially bullish for underlying conviction though details are absent. Mixed sentiment dominates RCOM (materiality 9/10) due to fraud risks offset by legal safeguards, while neutral sentiment prevails in the other low-materiality (3/10) filings. BANKEX implications highlight SBI's proactive DII positioning versus PNB's legacy lending risks, with no forward-looking guidance changes or capital allocation details noted. Portfolio-level pattern: Selective DII interest amid isolated bank exposure to fraud.

1 high priority 2 medium 3 total filings
· daily

BSE Pharma Sector Regulatory Filings — May 09, 2026

Across the three BSE PHARMA filings, overarching themes include routine corporate governance at Biocon, an upcoming board meeting at Torrent Pharmaceuticals with potential FY26 results, dividend, and fundraising catalysts, and sharply deteriorating financials at small-cap Natural Biocon (India), highlighting vulnerability in smaller players. Period-over-period trends reveal extreme underperformance at Natural Biocon with FY26 net sales plunging 69.5% YoY to ₹254.31 L and Q4 sales down 35% YoY to ₹87.85 L, swinging to a pre-tax loss of ₹4.00 L from FY25 profit of ₹5.96 L, while total income fell to ₹254.54 L (-69.5% YoY) amid expenses at ₹258.54 L. No period data for Biocon or Torrent, but Torrent's board meeting on May 22, 2026, signals imminent FY26 disclosures and capital raise options via QIP or bonds, potentially indicating growth ambitions or balance sheet needs. Portfolio-level patterns show stability in larger constituents (Biocon neutral postal ballot) contrasting stark declines in micro-caps like Natural Biocon, with no insider activity, M&A, or buybacks noted across filings. Sector implications point to caution on small pharma amid revenue collapses, while monitoring large-cap earnings for dividend and funding signals amid clean balance sheets (Natural Biocon debt-free). This digest flags time-sensitive opportunities around Torrent's catalysts in a mixed sentiment environment (1 negative, 2 neutral).

3 medium 3 total filings
· daily

BSE Realty Real Estate Sector Regulatory Filings — May 09, 2026

Sobha Limited reported record FY26 real estate sales of ₹8,136 Cr, marking ~30% YoY growth driven by Bangalore (₹4,500 Cr) and NCR (₹2,450 Cr), with collections rising 26.1% YoY to ₹7,798 Cr and net debt turning negative at ₹800 Cr, signaling robust operational momentum and balance sheet strength in the BSE Realty sector. Deliveries surged 19% YoY to 5.4 million sq ft (3,188 homes), backed by ₹18,647 Cr unrecognized revenue poised for 30%+ EBITDA margins. However, sales missed analyst targets of ₹10,000 Cr due to launch delays, and current EBITDA margins (FY26 ₹503 Cr) lag historical guidance, with recovery eyed from Q3 FY27. Mixed sentiment reflects growth outperformance tempered by execution hiccups, positioning Sobha as a sector leader with high materiality (9/10). Key trends include accelerating sales/collections and negative leverage, implying positive sector tailwinds amid demand in key markets. Investors should monitor FY27 launches for sustained growth, as this single filing highlights realty's resilience but underscores launch timing risks.

1 medium 1 total filings
· daily

BSE Sensex 30 Stocks Regulatory Filings — May 08, 2026

Across 13 filings from BSE Sensex 30 constituents on May 8, 2026, dominant themes include robust capital returns via high dividends (SBI at 1735% payout), mixed Q4/FY26 earnings with revenue surges offset by margin pressures (Titan +46% Q4 revenue YoY but -135 bps EBIT margin; M&M +42% Q4 PAT YoY despite Farm impairments), and positive order inflows (L&T significant EPC win). Period-over-period trends show banking strength (SBI FY26 standalone profit +12.8% YoY to ₹80,032 Cr, GNPA -330 bps to 1.49%, CAR +115 bps to 15.40%) contrasting consumer margin compression, with deposits/advances growth (+4.7% YoY consolidated deposits, +5.4% advances). Portfolio-level patterns highlight shareholder-friendly capital allocation (SBI ₹17.35/share dividend, record May 16; Titan ₹15/share) amid scheduled catalysts like PowerGrid results on May 15 and UltraTech investor meet on May 18. No insider trading or pledges noted, but improving asset quality and order momentum signal sector resilience; however, Q4 profit deceleration (SBI +5.6% YoY standalone) warrants caution for rate-sensitive names.

1 high priority 12 medium 13 total filings
· daily

BSE Metal Sector Regulatory Filings — May 08, 2026

BSE Metal sector filings highlight an imminent earnings catalyst cluster with JSW Steel's board meeting and analyst call on May 14, 2026, and SAIL's board on May 15, 2026, to approve Q4/FY26 audited results, setting the stage for period-over-period revelations on revenue, margins, and operational metrics amid trading window closures. Vedanta Limited secured overwhelming shareholder approval (99.59% in favor) for a new Non-Executive Independent Director via postal ballot, signaling robust governance with minimal opposition (0.41%). JSW Steel's high materiality (8/10) update flags potential capital allocation decisions including dividend recommendations and long-term fundraising via QIP or NCDs, which could imply reinvestment needs or dilution risks. Neutral sentiment dominates JSW and SAIL filings, while Vedanta's is positive; no insider trading activity disclosed across filings, but closed trading windows limit visibility into management conviction. Portfolio-level themes include earnings anticipation without prior QoQ/YoY previews, governance strengthening at Vedanta, and proactive capital planning at JSW. Investors should prioritize pre-results positioning, watching for guidance updates, dividend yields, and funding terms that could drive relative outperformance in the metal/mining space.

5 medium 5 total filings
· daily

BSE Auto Sector Regulatory Filings — May 08, 2026

The India BSE AUTO sector shows mixed performance across 6 filings, with revenue growth in Balkrishna Industries (+3.9% YoY FY26 to ₹10819.95 Cr, +7.1% Q4) contrasting sharp PBT declines (-25% YoY FY26 to ₹1616.82 Cr, -16.9% Q4), while Mahindra & Mahindra delivered robust PAT growth (+42% Q4 YoY, +35% FY26) driven by Auto (+33% profit, +19% volumes, +80 bps margins) and EV market share gains (#1 position, +260 bps revenue share). M&A activity signals structural simplification and expansion, including TVS Motor's sanctioned merger of wholly-owned subsidiary Sundaram Auto (effective post-RoC filing, Appointed Date Apr 1, 2025) for synergies and Bharat Forge's 30% acquisition in Fortuna Engineering (₹478.45 premium/share, now associate). Capital allocation remains shareholder-friendly with Balkrishna's Rs. 4 final dividend (200% on Rs. 2 FV) amid rising capex (CWIP +151% to ₹2472.46 Cr) and cash from ops +27% YoY to ₹2223.94 Cr. UNO Minda's upcoming board meeting (May 16, 2026) for FY26 results and fundraising authorization adds near-term catalysts. Portfolio-level trends highlight profit pressures from depreciation/costs in ancillaries/tyres (Balkrishna outlier down vs M&M up), EV tailwinds, and M&A for efficiency, positioning leaders for outperformance amid moderating growth.

2 high priority 4 medium 6 total filings
· daily

BSE FMCG Sector Regulatory Filings — May 08, 2026

The India BSE FMCG stream filings are dominated by Tata Consumer Products Limited's (5/9 filings) strong FY26 audited results, showing revenue from operations up 15% YoY to ₹14,700.05 Cr and Q4 FY26 up 16% YoY to ₹3,891.76 Cr, with total income +15% YoY to ₹15,249.10 Cr, unmodified audit opinion, and a recommended ₹10/share dividend (1000% on ₹1 face value) payable post June 2026 AGM. Other filings from Britannia (2), Radico Khaitan (1), and Nestle India (1) are neutral investor/analyst meets and dividend claim notices, with no UPSI shared. Period-over-period trends highlight Tata's revenue acceleration in Q4 vs FY average, offset by higher input costs (purchase of stock-in-trade +24.6% YoY to ₹4,953.95 Cr, employee expenses +24.8% YoY to ₹745 Cr), but finance costs down 55.1% YoY to ₹90.99 Cr signals improving leverage. No insider trading, M&A, or forward guidance changes reported across filings; capital allocation favors Tata's shareholder returns via high dividend payout. Sector theme: Steady post-earnings investor engagement amid Tata's outperformance, positioning it as a relative winner in FMCG. Portfolio implication: Accumulate Tata ahead of AGM catalyst, monitor peers for Q4 transcripts.

9 medium 9 total filings
· daily

BSE IT Technology Sector Regulatory Filings — May 08, 2026

In the India BSE IT stream for May 8, 2026, two neutral sentiment filings underscore proactive investor communication amid FY26 earnings season rollout. NIIT Limited (new filing, materiality 6/10) announced an analyst/investor group call on May 14, 2026, to discuss audited FY26 financial results (ended March 31, 2026), with pre-registration open and materials to follow on its website. KPIT Technologies Limited (prior context, materiality 2/10) disclosed the availability of its post-earnings investor meet audio recording on its investor page, following May 7 and May 4 intimations, but included no new financial metrics. No period-over-period trends, insider activity, capital allocation, or forward-looking guidance were detailed in these disclosures, limiting quantitative insights. Cross-filing comparison shows NIIT's higher materiality and upcoming event signaling greater near-term attention versus KPIT's retrospective update. Sector theme emerges of enhanced transparency via accessible calls/recordings, potentially revealing FY26 operational metrics, margins, and guidance. Actionable implication: Prioritize NIIT call for potential outperformance signals in BSE IT portfolio.

2 medium 2 total filings
· daily

BSE Bankex Banking Sector Regulatory Filings — May 08, 2026

Dominant themes across the 12 BSE BANKEX filings include robust dividend declarations from State Bank of India (SBI) at ₹17.35/share (1735% on FV ₹1) and Bank of Baroda (BoB) at ₹8.50/share (FV ₹2), underscoring strong capital allocation to shareholders amid FY26 results. SBI reported stellar FY26 standalone net profit growth of 12.8% YoY to ₹80,032 Cr and consolidated 7.8% to ₹85,168 Cr, with gross NPAs improving to 1.49% from 1.82% YoY, deposits +4.7% consolidated, and advances +5.4%; BoB showed modest net profit +2.25% YoY to ₹20,021 Cr but strong advances +16.57% YoY to ₹1,409,094 Cr and deposits +12% YoY, though with CAR slippage to 15.82% from 17.19%. Period-over-period trends reveal improving asset quality (NPAs down across SBI/BoB) and deposit/advance growth averaging 10-12% YoY, but mixed profitability with Q4 slowdowns (SBI +5.6% YoY standalone). Yes Bank's RBI penalty introduces regulatory risk, while minor ESOP allotments at Yes Bank (0.016% dilution) and ICICI Bank signal neutral employee incentives. Portfolio-level implications favor dividend capture plays before May 16 (SBI) and June 5 (BoB) record dates, with BoB's ₹6,000 Cr capital raise plan through 2027 providing growth funding amid CAR concerns. Overall sector sentiment leans positive on capital returns but mixed on profitability momentum.

12 medium 12 total filings
· daily

BSE Pharma Sector Regulatory Filings — May 08, 2026

In the India BSE PHARMA stream, five filings highlight a mix of capital allocation strength, upcoming earnings catalysts, and ongoing corporate restructuring amid neutral-to-positive sentiment. Aurobindo Pharma's near-complete buyback (99.999% utilization, 5.43x oversubscription) signals strong shareholder returns and management confidence, contrasting with routine compliance in Biocon's QIP monitoring. Zydus Lifesciences and Mankind Pharma flag imminent Q4FY26/FY26 results disclosures on May 19-20, with trading window closures indicating material updates ahead. Apollo Hospitals advances its composite scheme of arrangement via NCLT-approved meeting rescheduling to June 2026. Portfolio-level, no adverse period-over-period trends reported; instead, capital allocation favors buybacks over dividends, with cluster of earnings events poised to drive volatility and sector rotation opportunities.

2 high priority 3 medium 5 total filings
· daily

BSE Realty Real Estate Sector Regulatory Filings — May 08, 2026

The India BSE REALTY stream highlights robust capital allocation and shareholder returns across key players, with Brigade Enterprises proposing a 1:3 bonus issue and capital increase to ₹400 Cr, signaling strong free reserves and growth confidence. Oberoi Realty dominates with three filings: declaring a 4th interim dividend of ₹2/share (record date May 14, 2026), and approving up to ₹4,000 Cr debt raise via NCDs, indicating aggressive expansion plans amid positive sentiment. DLF schedules audited FY25-26 results and dividend recommendation for May 13, 2026 board meeting, a major catalyst. Phoenix Mills has a low-materiality investor roadshow on May 13, 2026. No period-over-period financial trends, insider trades, or M&A details disclosed across filings, but capital actions suggest sector resilience; Oberoi's repeated dividend filings reinforce payout consistency. Portfolio-level theme: heightened activity around dividends and funding, with neutral-to-positive sentiment (4/6 positive/neutral), no bearish signals.

6 medium 6 total filings
· daily

BSE Sensex 30 Stocks Regulatory Filings — May 07, 2026

Across 21 filings from BSE Sensex 30 constituents (with some peripheral banks/NBFCs), dominant themes include pre-earnings board meetings for Q4/FY26 results and dividends (ITC May 21, BEL May 19, Tata Steel May 15), signaling FY26 closure amid stable demand. Positive FMCG momentum led by HUL's 8% Q4 revenue growth (7% USG, highest in 12Q) and 23.7% EBITDA margin at guidance high-end, contrasting Reliance's cancelled Rs20cr acquisition (negative). Banking sector sees RBI approvals for stake buys (HDFC up to 9.95% in ICICI, Kotak 9.99% in City Union), boosting liquidity/valuation potential. Infra wins for L&T (Large* orders Rs2.5-5k Cr in buildings), NTPC's JV buyout (turnover +340% YoY to Rs1.28L in FY25), and Airtel's new ZTA product launch highlight growth catalysts. Capital allocation trends favor dividends (multiple boards) and debt raises (Mahindra Finance Rs1k Cr NCDs at 7.9%, SBI $2Bn bonds). No insider trading patterns noted; sentiment skews positive/neutral (14/21), with limited period declines (e.g., NTPC JV -15% prior YoY). Portfolio-level: Revenue acceleration in select cos (HUL +8% YoY, NTPC +340%), but no broad margin compression; watch May 12-21 earnings cluster for guidance.

2 high priority 19 medium 21 total filings
· daily

BSE Metal Sector Regulatory Filings — May 07, 2026

The three filings in the India BSE METAL stream underscore the kickoff of Q4 FY26 earnings disclosures among key constituents Adani Enterprises and Tata Steel. Adani Enterprises released the earnings call transcript from April 30, 2026, linking to detailed discussions on audited standalone and consolidated results for the quarter and year ended March 31, 2026, enabling investor deep dives despite no metrics in the notice itself. Tata Steel (two filings, one new contextually) announced a high-materiality (9/10 and 8/10) board meeting on May 15, 2026, to approve audited standalone/unaudited consolidated FY26 results and recommend dividends if any, with trading window closed since March 25, 2026. All filings carry neutral sentiment, reflecting procedural updates rather than directional shifts. No period-over-period comparisons, financial ratios, or insider activity disclosed, limiting quantitative trend synthesis at portfolio level. Overarching theme: Imminent catalysts in metals sector, with transparency via Adani transcript and Tata dividend potential signaling capital allocation focus. Market implication: Position for post-results volatility, review Adani transcript urgently for hidden insights on metal trends.

1 high priority 2 medium 3 total filings
· daily

BSE Auto Sector Regulatory Filings — May 07, 2026

The India BSE AUTO stream reveals resilient YoY growth across key players, with MRF Limited posting consolidated total income up 11% to Rs 31,654 Cr and net profit surging 30% to Rs 2,426 Cr, while Bharat Forge achieved consolidated revenues of Rs 16,812 Cr (+11.2% YoY) despite standalone declines of 5.1% YoY to Rs 8,396 Cr. QoQ trends are mixed, with MRF Q4 revenue down 0.3% to Rs 7,908 Cr and Bharat Forge Q4 standalone up 8.5% to Rs 2,260 Cr, highlighting domestic recovery amid export challenges. Mahindra & Mahindra Financial Services is raising Rs 1,000 Cr via secured debentures at 7.90% coupon (allotment May 12, 2026), signaling funding for auto finance expansion but increasing leverage. Capital allocation favors shareholders via MRF's Rs 229 final dividend (total FY26 Rs 235/share), while Bharat Forge guides 25% revenue growth for Indian operations in FY27 backed by Rs 4,814 Cr new orders and Rs 10,961 Cr order book. Mixed sentiment prevails due to raw material cost pressures, monsoon risks, and overseas weaknesses, but strong order inflows and profit beats position auto ancillaries for upside. Portfolio-level theme: 2/3 filings with enriched financials show average 11% YoY revenue growth and 18% profit growth, outperforming broader auto sector expectations amid capacity expansions.

6 medium 6 total filings
· daily

BSE FMCG Sector Regulatory Filings — May 07, 2026

FMCG sector filings highlight earnings season kickoff with strong FY26 results from key players like HUL (8% Q4 revenue growth YoY, 5% FY USG) and Britannia (6.7% FY revenue growth YoY, 16.5% net profit growth), contrasted by Q4 softness in Britannia (-5.1% revenue QoQ) and Emami's target IncNut showing revenue declines (-15.3% YoY FY24, -10.9% FY25). Capital allocation remains shareholder-friendly with Dabur recommending Rs 5.50 final dividend (550%) and Britannia Rs 90.50, signaling stable cash flows amid labor cost pressures (Britannia employee expenses +16.9% YoY). M&A activity surges with Emami's Rs 321 Cr acquisition of 60% in personalized beauty firm IncNut (closing within 30 days), reinforcing digital BPC push despite target's declining turnover. ITC advances subsidiary mergers (effective June 1, 2026) and schedules board meeting May 21 for FY26 results/dividend. Neutral sentiment dominates procedural filings (earnings calls, board meets), but positive tones on growth execution (HUL direct reach +2L outlets) and strategic buys outweigh mixed signals from JV losses (Dabur ~Rs 1.8 Cr immaterial) and target weaknesses. Portfolio-level: 3/5 reporting companies show FY revenue growth >6% YoY, but Q4 QoQ dips flag seasonal demand risks; upcoming catalysts cluster in May-July (board meets, record dates). Actionable: Favor HUL/Dabur for growth/dividends, monitor Emami integration.

1 high priority 17 medium 18 total filings
· daily

BSE IT Technology Sector Regulatory Filings — May 07, 2026

Filings from BSE IT constituents reveal Sonata Software as a standout with FY26 audited results showing revenue surging 37.9% YoY to ₹136,676 lakhs and profit rising 30.4% YoY to ₹27,873 lakhs, alongside a recommended final dividend of ₹4.15 per share (415% on ₹1 face value). TCS affirmed full SEBI regulatory compliance with no deviations or fines for FY26. Multiple investor engagement events scheduled for May 12-13, 2026, including Infosys' New York roadshow, NIIT's results discussion call, and MphasiS' Mumbai conference, signal heightened post-earnings interaction amid FY26 wrap-up. Balance sheet improvements at Sonata include non-current assets up to ₹38,919 lakhs (from ₹20,099 lakhs YoY) and trade receivables at ₹89,731 lakhs, reflecting growth but potential working capital stretch. Overall sentiment is positive (3/6 filings), with neutral events underscoring routine Q4/FY disclosures; no insider trading, M&A, or guidance changes noted, but unmodified audit opinions and dividend proposal highlight capital return focus. Sector implications point to robust IT services growth led by midcaps, with catalysts clustered imminently for alpha capture.

6 medium 6 total filings
· daily

BSE Bankex Banking Sector Regulatory Filings — May 07, 2026

BSE BANKEX filings reveal a surge in RBI-approved inter-bank stake acquisitions, with HDFC Bank cleared for up to 9.95% in ICICI Bank and Kotak Mahindra Bank for 9.99% in City Union Bank, both via letters dated May 6, 2026, signaling potential sector consolidation and strategic cross-holdings among top players. State Bank of India announced an Executive Committee meeting on May 12, 2026, to approve up to US$2 Billion long-term fundraising via Reg-S/144A bonds in FY 2026-27, reflecting proactive capital management amid growth needs. Punjab National Bank's investor/analyst meet on May 7, 2026, shared only public info, maintaining status quo. Sentiments skew positive to neutral with high materiality (avg 7/10) for acquisition and fundraising events, no bearish tones. No period-over-period financial trends, insider trading, or operational metrics disclosed across filings, focusing instead on regulatory and governance updates. Key implications: Enhanced liquidity and alliances for targets, funding firepower for SBI, and a catalyst calendar clustered around May 12; portfolio-level theme of RBI facilitating ~10% stakes under 2025 Directions, potentially stabilizing BANKEX amid economic cycles.

4 medium 4 total filings
· daily

BSE Pharma Sector Regulatory Filings — May 07, 2026

In the India BSE PHARMA stream, filings highlight an approaching earnings catalyst season with Mankind Pharma's board meeting on May 19, 2026, for FY26 audited results and NCD security realignment post-₹1,250 Cr redemption, alongside Lupin's stellar FY26 results showing 15% YoY revenue growth to ₹195,127M and 60% YoY PAT surge to ₹63,666M, and GlaxoSmithKline's low-materiality investor meet on May 13. Lupin's Q4 FY26 delivered 17% YoY revenue growth to ₹52,346M and 68% PAT jump to ₹21,637M, driven by robust operating cash flow up to ₹55,399M from ₹24,447M YoY, though tempered by cash equivalents decline to ₹1,116M and new ₹5,769M borrowings. Capital allocation remains shareholder-friendly with Lupin's ₹18/share dividend recommendation (₹8,229M total). Sector themes point to positive momentum from Lupin's outperformance amid neutral event-driven filings, signaling potential upside pre-earnings but with debt management watchpoints. Portfolio-level, 1/3 companies (Lupin) reported strong double-digit growth, contrasting neutral sentiment elsewhere, implying selective bullish rotation into high-conviction names ahead of May catalysts.

3 medium 3 total filings